NCT06362057 Biomechanical Effects of Digitally Constructed Subperiosteal Implants
| NCT ID | NCT06362057 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Menoufia University |
| Condition | Bone Loss |
| Study Type | OBSERVATIONAL |
| Enrollment | 9 participants |
| Start Date | 2024-04-04 |
| Primary Completion | 2025-05-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 9 participants in total. It began in 2024-04-04 with a primary completion date of 2025-05-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Subperiosteal implants were first introduced in 1940 and then used worldwide for the treatment of edentulous maxilla or mandible with advanced bone atrophy.
Eligibility Criteria
Inclusion Criteria: * A 3D image of an edentulous maxilla bone derived from a computed tomography scan of an adult patient. * Maxilla with Cawood and Howell class 4 or 5 classification Exclusion Criteria: * A 2D image of an edentulous maxilla bone * A non atrophied maxilla
Contact & Investigator
Mohammed A. El-Sawy, PhD
STUDY CHAIR
Menoufia University
Frequently Asked Questions
Who can join the NCT06362057 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 70 Years, studying Bone Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06362057 currently recruiting?
Yes, NCT06362057 is actively recruiting participants. Contact the research team at Dr_sawy@windowslive.com for enrollment information.
Where is the NCT06362057 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT06362057 clinical trial?
NCT06362057 is sponsored by Menoufia University. The principal investigator is Mohammed A. El-Sawy, PhD at Menoufia University. The trial plans to enroll 9 participants.